• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?

作者信息

Bailey Stephen R

机构信息

Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA.

出版信息

Catheter Cardiovasc Interv. 2004 Apr;61(4):492-3. doi: 10.1002/ccd.20023.

DOI:10.1002/ccd.20023
PMID:15065144
Abstract
摘要

相似文献

1
Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?腺苷与硝普钠联合治疗与单独使用腺苷[应为腺苷]治疗血管造影无复流现象的比较：1加1等于11吗？
Catheter Cardiovasc Interv. 2004 Apr;61(4):492-3. doi: 10.1002/ccd.20023.
2
Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.腺苷与硝普钠联合治疗与单独使用腺苷治疗血管造影无复流现象的比较。
Catheter Cardiovasc Interv. 2004 Apr;61(4):484-91. doi: 10.1002/ccd.20010.
3
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.冠状动脉内联合注射腺苷和硝普钠可逆转血管成形术中的慢血流/无复流现象：一种缺血预处理的临床情况。
Can J Physiol Pharmacol. 2007 Mar-Apr;85(3-4):476-82. doi: 10.1139/y07-013.
4
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.急性心肌梗死直接经皮冠状动脉介入治疗中血栓抽吸术后冠状动脉内硝普钠与腺苷预防无复流的随机评估：REOPEN-AMI研究方案
J Cardiovasc Med (Hagerstown). 2009 Jul;10(7):585-92. doi: 10.2459/JCM.0b013e32832b3571.
5
Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006;152:887.e9-14).
Am Heart J. 2007 May;153(5):e25; author reply e27. doi: 10.1016/j.ahj.2007.01.015.
6
Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.经皮冠状动脉介入治疗后使用一氧化氮供体硝普钠治疗无复流和血流受损：初步人体临床经验
J Am Coll Cardiol. 2001 Apr;37(5):1335-43. doi: 10.1016/s0735-1097(01)01138-x.
7
[Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Zhonghua Yi Xue Za Zhi. 2005 Aug 17;85(31):2169-70.
8
Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.大剂量腺苷和维拉帕米局部灌注成功治疗顽固性无复流——病例报告
Angiology. 2001 Feb;52(2):137-41. doi: 10.1177/000331970105200208.
9
Has my patient achieved adequate myocardial reperfusion?我的患者是否实现了充分的心肌再灌注？
Circulation. 2003 Aug 5;108(5):504-7. doi: 10.1161/01.CIR.0000082932.69023.74.
10
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.原发性冠状动脉支架置入患者中，腺苷可改善微血管再灌注并减小梗死面积。
Am J Cardiol. 2005 Nov 15;96(10):1410-5. doi: 10.1016/j.amjcard.2005.06.090. Epub 2005 Sep 27.